Literature DB >> 19451291

Trypanocidal activity of 8-methyl-5'-{[(Z)-4-aminobut-2-enyl]-(methylamino)}adenosine (Genz-644131), an adenosylmethionine decarboxylase inhibitor.

Cyrus J Bacchi1, Robert H Barker, Aixa Rodriguez, Bradford Hirth, Donna Rattendi, Nigel Yarlett, Clifford L Hendrick, Edmund Sybertz.   

Abstract

Genzyme 644131, 8-methyl-5'-{[(Z)-4-aminobut-2-enyl](methylamino)}adenosine, is an analog of the enzyme activated S-adenosylmethionine decarboxylase (AdoMetDC) inhibitor and the trypanocidal agent MDL-7381, 5-{[(Z)-4-aminobut-2-enyl](methylamino)}adenosine. The analog differs from the parent in having an 8-methyl group on the purine ring that bestows favorable pharmacokinetic, biochemical, and trypanocidal activities. The compound was curative in acute Trypanosoma brucei brucei and drug-resistant Trypanosoma brucei rhodesiense model infections, with single-dose activity in the 1- to 5-mg/kg/day daily dose range for 4 days against T. brucei brucei and 25- to 50-mg/kg twice-daily dosing against T. brucei rhodesiense infections. The compound was not curative in the TREU 667 central nervous system model infection but cleared blood parasitemia and extended time to recrudescence in several groups. This study shows that AdoMetDC remains an attractive chemotherapeutic target in African trypanosomes and that chemical changes in AdoMetDC inhibitors can produce more favorable drug characteristics than the lead compound.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451291      PMCID: PMC2715600          DOI: 10.1128/AAC.00076-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.

Authors:  C J Bacchi; R Brun; S L Croft; K Alicea; Y Bühler
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense.

Authors:  C J Bacchi; H C Nathan; T Livingston; G Valladares; M Saric; P D Sayer; A R Njogu; A B Clarkson
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapy.

Authors:  F W Jennings; D D Whitelaw; G M Urquhart
Journal:  Parasitology       Date:  1977-10       Impact factor: 3.234

4.  Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine.

Authors:  T L Byers; T L Bush; P P McCann; A J Bitonti
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

5.  In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei.

Authors:  A H Fairlamb; G B Henderson; C J Bacchi; A Cerami
Journal:  Mol Biochem Parasitol       Date:  1987-06       Impact factor: 1.759

6.  Antitrypanosomal activity of purine nucleosides can be enhanced by their conversion to O-acetylated derivatives.

Authors:  J R Sufrin; D Rattendi; A J Spiess; S Lane; C J Marasco; C J Bacchi
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

7.  New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin.

Authors:  A B Clarkson; E J Bienen; C J Bacchi; P P McCann; H C Nathan; S H Hutner; A Sjoerdsma
Journal:  Am J Trop Med Hyg       Date:  1984-11       Impact factor: 2.345

8.  Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor.

Authors:  C J Bacchi; H C Nathan; N Yarlett; B Goldberg; P P McCann; A J Bitonti; A Sjoerdsma
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

9.  Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase.

Authors:  A J Bitonti; T L Byers; T L Bush; P J Casara; C J Bacchi; A B Clarkson; P P McCann; A Sjoerdsma
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

10.  New insights into the design of inhibitors of human S-adenosylmethionine decarboxylase: studies of adenine C8 substitution in structural analogues of S-adenosylmethionine.

Authors:  Diane E McCloskey; Shridhar Bale; John A Secrist; Anita Tiwari; Thomas H Moss; Jacob Valiyaveettil; Wesley H Brooks; Wayne C Guida; Anthony E Pegg; Steven E Ealick
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

View more
  16 in total

1.  Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity.

Authors:  Anthony J Brockway; Oleg A Volkov; Casey C Cosner; Karen S MacMillan; Stephen A Wring; Thomas E Richardson; Michael Peel; Margaret A Phillips; Jef K De Brabander
Journal:  Bioorg Med Chem       Date:  2017-08-03       Impact factor: 3.641

2.  Species-Selective Pyrimidineamine Inhibitors of Trypanosoma brucei S-Adenosylmethionine Decarboxylase.

Authors:  Oleg A Volkov; Anthony J Brockway; Stephen A Wring; Michael Peel; Zhe Chen; Margaret A Phillips; Jef K De Brabander
Journal:  J Med Chem       Date:  2018-01-05       Impact factor: 7.446

3.  Spermidine synthase is required for virulence of Leishmania donovani.

Authors:  Caslin Gilroy; Tamara Olenyik; Sigrid C Roberts; Buddy Ullman
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

4.  High affinity S-Adenosylmethionine plasma membrane transporter of Leishmania is a member of the folate biopterin transporter (FBT) family.

Authors:  Larbi Dridi; Amin Ahmed Ouameur; Marc Ouellette
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

5.  Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of Potential Drugs for Human African Trypanosomiasis.

Authors:  Donald A Patrick; J Robert Gillespie; Joshua McQueen; Matthew A Hulverson; Ranae M Ranade; Sharon A Creason; Zackary M Herbst; Michael H Gelb; Frederick S Buckner; Richard R Tidwell
Journal:  J Med Chem       Date:  2016-12-19       Impact factor: 7.446

6.  Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.

Authors:  Oleg A Volkov; Casey C Cosner; Anthony J Brockway; Martin Kramer; Michael Booker; Shihua Zhong; Ariel Ketcherside; Shuguang Wei; Jamie Longgood; Melissa McCoy; Thomas E Richardson; Stephen A Wring; Michael Peel; Jeffrey D Klinger; Bruce A Posner; Jef K De Brabander; Margaret A Phillips
Journal:  ACS Infect Dis       Date:  2017-04-07       Impact factor: 5.084

Review 7.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

8.  Product feedback regulation implicated in translational control of the Trypanosoma brucei S-adenosylmethionine decarboxylase regulatory subunit prozyme.

Authors:  Yanjing Xiao; Suong Nguyen; Sok Ho Kim; Oleg A Volkov; Benjamin P Tu; Margaret A Phillips
Journal:  Mol Microbiol       Date:  2013-05-02       Impact factor: 3.501

Review 9.  Polyamines in protozoan pathogens.

Authors:  Margaret A Phillips
Journal:  J Biol Chem       Date:  2018-10-17       Impact factor: 5.157

10.  Effects of the green tea catechin (-)-epigallocatechin gallate on Trypanosoma brucei.

Authors:  Patrick A Vigueira; Sunayan S Ray; Ben A Martin; Marianne M Ligon; Kimberly S Paul
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-09-29       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.